Valbenazine drug found to significantly reduce tardive dyskinesia or involuntary movements caused by antipsychotic medications.
Highlights
- Tardive dyskinesia or involuntary movement is a serious side effect of antipsychotic medications.
- A recent study finds that the use of valbenazine drug may be effective in significantly reducing the involuntary movements.
Dr. Hauser, wrote, "One approach to managing tardive dyskinesia is to discontinue antipsychotic treatment or reduce the dosage, but these options are not always feasible, because withdrawal can exacerbate tardive dyskinesia symptoms or have a negative impact on psychiatric status. Moreover, tardive dyskinesia symptoms often persist even after discontinuation or dosage reduction."
Clinical Trial
The Phase 3 placebo-controlled clinical trial was carried out on 225 people with schizophrenia, schizoaffective disorder or mood disorder.
The findings of the trial unveiled that:
Around 40% of the patients who received 80mg/day of valbenazine drug significantly reduced involuntary movements by at least 50% when compared to just 8% in placebo control
Tardive Dyskinesia
Tardive dyskinesia disorder involves involuntary movements, and is considered to be a serious side effect of antipsychotic medications.
Symptoms of Tardive Dyskinesia
- Finger movements
- Facial expression showing pain
- Jaw swinging
- Repetitive chewing
- Tardive dyskinesia - (https://medlineplus.gov/ency/article/000685.htm )
Source-Medindia